Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Cholic Acid Series > Glycoursodeoxycholic Acid CAS 64480-66-6

Glycoursodeoxycholic Acid CAS 64480-66-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 64480-66-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS No::
64480-66-6
Appearance::
White To Almost White Powder To Crystal
Molecular Formula::
C26H43NO5
Molecular Weight::
449.62
EINECS NO::
1592732-453-0
MDL NO.::
MFCD00137427
CAS No::
64480-66-6
Appearance::
White To Almost White Powder To Crystal
Molecular Formula::
C26H43NO5
Molecular Weight::
449.62
EINECS NO::
1592732-453-0
MDL NO.::
MFCD00137427
Glycoursodeoxycholic Acid CAS 64480-66-6

Product Description:

Product Name: Glycoursodeoxycholic Acid CAS 64480-66-6

Synonyms:

3.α.,7.beta.-Dihydroxy-5.beta.-cholanoylglycine;

N-(3.α.,7.beta.-Dihydroxy-5.beta.-cholan-24-oyl)glycine;

N-[(3.α.,5.beta.,7.beta.)-3,7-Dihyd.

Chemical & Physical Properties

Appearance:White to Almost white powder to crystal

Assay: NLT98%

Melting Point: 232-235°C

chemical property :Soluble in DMF: 10 mg/ml; DMSO: 10 mg/ml; DMSO:PBS (pH 7.2) (1:4): 0.2 mg/ml; Ethanol: 1 mg

 

Application: Glycoursodeoxycholic Acid (GUDCA) is a significant bile acid that emerges as a metabolite of Ursodeoxycholic Acid, which is used as an anticholelithogenic. As a secondary bile acid, GUDCA originates from the conversion of chenodeoxycholic acid (CDCA) by intestinal bacteria and occupies a prominent position in the bile acid pool of humans and other mammals, contributing to various physiological processes. It assumes a vital role in the enterohepatic circulation, which governs the absorption and excretion of bile acids, and has become a subject of extensive laboratory research, finding utility across diverse scientific applications. GUDCA functions as an agonist of the farnesoid X receptor (FXR), a nuclear receptor pivotal in regulating bile acid homeostasis. Through binding and activation of FXR, GUDCA influences the transcriptional activity of FXR, thereby modulating genes involved in bile acid metabolism and transport. Furthermore, GUDCA exhibits the capacity to modulate the activity of several enzymes associated with lipid metabolism, including lipoprotein lipase, acyl-coenzyme A synthetase, and acyl-CoA oxidase. It also exerts influence over the expression of genes implicated in the metabolism of lipids, carbohydrates, and proteins. Additionally, GUDCA displays notable anti-inflammatory, anti-apoptotic, and antioxidant activities.

 

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.